1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
The Science of Hitting
The Science of Hitting
Articles (418) 

Travelers: Upgraded, Target 30% Higher

September 20, 2011 | About:

The Travelers Companies (NYSE:TRV), a provider of a wide range of commercial and personal P&C insurance products, has lagged the market over the past six months, falling more than 13% compared to mid-single digit declines in the S&P 500 and DJIA. As of June 30, 2011, the company had more than $25 billion in equity, equal to a book value just shy of $60 per share; the stock, by comparison, has been fighting the $50 hurdle for the past month, and trades nearly 20% below book value.

On Tuesday, the stock moved around 3% higher (before giving gains back late in the day) on an upgrade by Goldman Sachs (GS) analyst Michael Nannizzi from sell to buy ($63 target). He noted, among other things, the company’s 3.3% dividend yield, which is roughly 140 basis points above the yield on 10-year Treasuries.

In the second quarter, the company reported that total after-tax catastrophe costs nearly $1.1 billion, due to the tornadoes and hail storms in the United States during April and May. While the disasters caused a short term stoppage in huge share buybacks, management made their long term intentions extremely clear: “On the premise that weather patterns return to more normal levels and our profitability returns to historical levels, and to the extent that the capital can be put back to work in our business for growth opportunities, we will continue buying back shares.”

Even with the temporary reduction in buybacks, management can still tout impressive numbers: Year-to-date repurchases total $1.3 billion of common stock, with a total trailing twelve month repurchase of $3.5 billion. Those two numbers have reduced diluted shares outstanding by 3.5% and 11.9%, respectively. Since the end of 2007, the number of shares outstanding has decreased by more than one-third.

For now, the company needs to pay claims, and buybacks are on hold. However, the important realization for long term shareholders is that the resulting 25% price decline from the low $60s in May is really just an opportunity. For one, it’s a chance to buy more shares in a company that has increased BVPS at a rate of 10.5% and 9.3% in the last five and ten years, respectively, for 20% below book. Secondly, management will be able to continue repurchasing shares (pending any increase) at bargain-bin prices, which will further compound strong business results in expansion of book value per share.

In the end, the short-term decline only sweetens the opportunity for long-term gain. For investors who can see past next quarter, shares of TRV may be worth a second look.

About the author:

The Science of Hitting
I'm a value investor with a long term focus.

As it relates to portfolio construction, my goal is to make a small number of meaningful decisions. In the words of Charlie Munger, my preferred approach is "Patience followed by pretty aggressive conduct." I run a concentrated portfolio, with a handful of equities accounting for the majority of my portfolio (currently two). In the eyes of a businessman, I believe this is adequate diversification.

Rating: 4.8/5 (13 votes)

Comments

slam21
Slam21 - 5 years ago    Report SPAM
I like your take on this but make sure to mention the risks as well. Be aware that a significant portion of the earnings power of the recent years at TRV has come from prior year reserve releases rather than current year underwriting profits, so the pressure is on the P&C industry to get some pricing improvements coming through in the next 1-2 years. Otherwise, a "replacement earnings" issue for future profitability will become something to contend with.

As well, as long as interest rates are low, then future investment income results face a headwind.

At 20% below BV, the "risks or threats" noted in this comment are probably being considered by the market, but nonetheless its good to be aware.
The Science of Hitting
The Science of Hitting - 5 years ago    Report SPAM
Good points Slam21, I probably should have touched on the actual business operations and earnings of the past couple of years at TRV. I'll make sure to dig deeper into these areas when I write an article about the company's recent presentation at the Barclay's Capital Global Financial Services Conference.

Please leave your comment:


GuruFocus Mobile App


User Generated Screeners


clyfoong24 dec screen
pbarker46Shiller PE & Low Payout
pbarker46PB Stocks, Canada
DANGORDONJ GREEN 1
doniemaherScreen #23 - Lo Debt, Profitab
pbarker46PB Stocks, USA
narrogYacktman&safe&cheap
okijuh1203
DANGORDONROC 12-4-16
OGCAMGDelisting risk
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK